A novel obesity treatment drug targeting glucagon-like peptide-1  /  glucagon / glucose-dependent insulinotropic polypeptide receptor: retatrutide

doi:10.3969/j.issn.1672-3384.2024.04.004

A novel obesity treatment drug targeting glucagon-like peptide-1 / glucagon / glucose-dependent insulinotropic polypeptide receptor: retatrutide

WANG Wen-xuan, FENG Dong-mei, CHENG Mao-sheng, LIU Yang

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (4) : 17-20.

PDF(420 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (4) : 17-20. DOI: 10.3969/j.issn.1672-3384.2024.04.004

Comment of New Drug

A novel obesity treatment drug targeting glucagon-like peptide-1 / glucagon / glucose-dependent insulinotropic polypeptide receptor: retatrutide

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(4): 17-20 https://doi.org/10.3969/j.issn.1672-3384.2024.04.004

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(420 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-12-14	2024-04-24
Issue Date
2024-04-24

Please choose a citation manager

Content to export